Posted: July 03, 2025
Bulk Quantities and Custom Formulations Now Available for OEM and Enterprise Clients
San Francisco, CA – NeoBiotechnologies, a vertically integrated antibody manufacturer known for its uncompromising validation standards, announces the availability of all its monoclonal antibodies in bulk quantities and custom formulations. Tailored for OEM and enterprise partners in the in vitro diagnostics (IVD), companion diagnostics (CDx), and pharmaceutical sectors, this expansion enhances access to the same rigorously validated reagents trusted by leading global brands.
NeoBiotechnologies is the exclusive manufacturer of all its antibodies, which are developed and validated in-house to meet the highest standards of specificity, reproducibility, and performance consistency. Each antibody undergoes a multi-tiered validation pipeline, including orthogonal validation in line with IWGAV guidelines and comparative testing across hundreds of tumor types and normal tissues.
“We are proud to be the silent engine behind many of the industry’s top-performing antibodies,” said Brittany Jones, Director of Marketing at NeoBiotechnologies.
“This expansion enables OEM and pharmaceutical partners to source directly from the manufacturer with complete confidence in the validation, scale, and integrity behind every vial.”
Highlights for IVD, CDx, and Pharma Partners
Bulk Supply & Custom Formulations
Scalable solutions available in milligram to gram quantities, with tailored buffers, concentrations, and formats to support integration into commercial assays and drug development workflows.
True Manufacturer Advantage
All products are developed, produced, and validated in-house—ensuring full supply chain transparency, rapid turnaround, and consistent lot-to-lot performance.
Gold-Standard Validation
Antibodies are benchmarked against mRNA expression patterns and validated across a spectrum of normal and cancerous tissues—offering unmatched specificity and reliability.
Trusted by Industry Leaders
NeoBiotechnologies antibodies are widely integrated into clinical-grade IVD kits and diagnostic workflows, trusted by leading diagnostics companies under relabeling and OEM partnerships.
Flexible Partnership Models
Licensing, OEM, and co-development opportunities available to support companion diagnostics, LDTs, and targeted therapy pipelines.
Get in Touch
To explore OEM partnerships, custom formulations, or bulk pricing, visit www.neobiotechnologies.com or contact us directly at contact@neobiotechnologies.com.
